Reducing inflammation and protecting brain cells in Alzheimer's disease
Mitigating neuroinflammation and enhancing neuronal integrity in Alzheimer's disease
This study is looking at how a protein called MG53 might help reduce inflammation and protect brain cells in people with Alzheimer's disease, with the hope of finding new treatments to slow down the disease's progression.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10873859 on NIH RePORTER |
What this research studies
This research investigates how a protein called MG53 can help reduce inflammation and protect brain cells in patients with Alzheimer's disease. The approach involves administering recombinant human MG53 to potentially slow down the progression of neurodegeneration by enhancing neuronal integrity and mitigating neuroinflammation. The study utilizes animal models to understand how MG53 can cross the blood-brain barrier and provide therapeutic benefits. If successful, this research could lead to new treatment options for individuals suffering from Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.
Not a fit: Patients with other forms of dementia or neurological disorders unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel therapeutic approach to slow the progression of Alzheimer's disease and improve the quality of life for patients.
How similar studies have performed: Previous studies have shown promising results with similar approaches using MG53 in animal models, indicating potential for success in human applications.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Ma, Jianjie — University of Virginia
- Study coordinator: Ma, Jianjie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.